ALLR$0.87042.20%-0.0196
After Hours: 0.87-0.00 -0.05%
Allarity Therapeutics Inc (ALLR)
Date: 2026-10-30 16:00O: 0.8900H: 0.9046L: 0.8500C: 0.8704Vol: 168.8k
Allarity Therapeutics Inc stock is traded at $0.8704, with a volume of 168,752. It is down -2.20% in the last 24 hours and down -17.10% over the past month. Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States. It is focused on the clinical development of its lead program: Stenoparib, which is being co-developed with a drug specific DRP companion diagnostic.
Previous Close:
$0.89
Open:
$0.89
24h Volume:
168,752
Relative Volume:
1.47
Market Cap:
$13.85M
Revenue:
$345.00K
Net Income/Loss:
-$11.25M
P/E Ratio:
-
EPS:
-$0.7217
Net Cash Flow:
-$16.70M
1W Performance:
+0.58%
1M Performance:
-17.10%
6M Performance:
-35.53%
1Y Performance:
-37.83%
1-Day Range:
$0.85$0.9046
1-Week Range:
$0.85$0.96
52-Week Range:
$0.7687$1.84
Allarity Therapeutics Inc Stock (ALLR) Company Profile
Name
Allarity Therapeutics IncSector
HealthcareIndustry
BiotechnologyPhone
401-426-4664Address
24 SCHOOL ST., 2ND FLOOR, BOSTON, USACompare ALLR vs VRTX, REGN, MRNA, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALLR Allarity Therapeutics Inc | $0.8704 | $13.85M | $345.00K | -$11.25M | -$16.70M | -$0.7217 |
 VRTX Vertex Pharmaceuticals Inc | $558.88 | $141.65B | $12.34B | $4.34B | $3.71B | $16.87 |
 REGN Regeneron Pharmaceuticals Inc | $927.89 | $95.53B | $14.92B | $4.42B | $3.79B | $41.04 |
 MRNA Moderna Inc | $221.72 | $88.52B | $2.23B | -$3.19B | -$1.60B | -$8.15 |
 ARGX Argen X Se Adr | $892.87 | $56.15B | $4.16B | $1.29B | $734.26M | $19.58 |
 ONC Beone Medicines Ltd Adr | $370.33 | $41.89B | $5.76B | $514.49M | $1.10B | $4.48 |
